![Sandra E. Poole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandra E. Poole
Director/Board Member at
TRAVERE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-06-29
Profile
Teresa "Terri" Hilda Poole, OAM (born 28 January 1964) is an English-born Australian Paralympic tandem cyclist with a vision impairment. She was born in the English city of Manchester. She competed at the 1996 Atlanta Games, where she won two gold medals in the Women's Individual Pursuit Tandem open and the Women's Kilo Tandem open track cycling events, for which she received a Medal of the Order of Australia. Her pilot was Sandra Smith. She competed in the Women's 50/60k Tandem open event for road cycling but did not medal. *
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-18 | 34,000 ( 0.04% ) | 2 M $ | 2026-06-29 |
Sandra E. Poole active positions
| Companies | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Board Member | 2019-05-12 |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Chief Operating Officer | 2020-06-30 |
Former positions of Sandra E. Poole
| Companies | Position | End |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Director/Board Member | 2022-06-30 |
| VALNEVA SE | Director/Board Member | 2020-06-16 |
| CANDEL THERAPEUTICS, INC. | Chief Operating Officer | 2020-02-29 |
| LOGICBIO THERAPEUTICS, INC. | Chief Operating Officer | 2019-03-30 |
S. Poole Consulting LLC
 S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | 2018-02-28 |
Training of Sandra E. Poole
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
S. Poole Consulting LLC
S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Sandra E. Poole
